I couldn’t be more proud of our lab’s first major paper- comparing human bladder cancer to BBN Mouse model. No model is perfect- but we think there’s a reason this model has persisted over 40 years. @NCIgenomics. nature.com/articles/s4138…
Super excited that our review on T1 bladder cancer published in @NatRevUrol. We tried to pack as much as could. Bottom line: a lot more work to do on the clinical and translational sides for risk stratification and treatment #bladdercancernature.com/articles/s4158…
One of my favorite things about spring is our annual visiting professor. Now named after Anthony J Schaeffer. This year we hosted James Eastham from @MSKCancerCenter. @NM_Urology.
Ever wonder why NMIBCs respond (or don't) to pembrolizumab? We did, too! Here is our spatial analysis comparing identifying stromal and epithelial signatures of response to IV and intravesical pembrolizumab.
